Schizophrenia Bulletin Advance Access originally published online on February 15, 2006
Schizophrenia Bulletin 2006 32(2):297-298; doi:10.1093/schbul/sbj060
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org.
Implications for Future Research of "Medication-Free Research in Early Episode Schizophrenia"
2 VA Capitol Network (VISN 5) Mental Illness Research, Education, and Clinical Center, and Georgetown University School of Medicine
| The first 10% of the full text of this article appears below. |
As noted by Bola,1 treatment with antipsychotics early in the course of a schizophrenic illness has implications both for clinical care and research. This commentary will focus on the implications for clinical trials with patients who are early in the course of their schizophrenic illness. But first, I want to comment on the 1967 article that had inadequate detail to allow formal inclusion in the meta-analysis.2 Although the trial was originally designed as a
1To whom correspondence should be addressed; e-mail: nina2277@msn.com.